It is not known the extent to which this is a result of glucoregulation by metformin, accomplished by inhibition of hepatic gluconeogenesis and improvement of insulin sensitivity in tissues leading to reduced oxidative stress in the liver,57 and/or a direct impact of metformin in reducing cancer risk via regulation of cellular signalling. Here, INS is linked to cancer.